| Financial Year |
March 31 2023 |
| Monetary Funds |
635,871,239.23 |
| Held-for-trading Financial Assets |
1,632,215.43 |
| Notes Receivable |
53,939,397.00 |
| Accounts Receivable |
4,144,521,573.55 |
| Advances to Suppliers |
186,071,325.69 |
| Other Receivables |
470,409,895.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
375,146,512.19 |
| Total Current Assets |
5,900,133,570.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
82,381,524.70 |
| Long-term Equity Investment |
96,195,096.49 |
| Investment Properties |
-- |
| Fixed Assetes |
6,419,649.34 |
| Under-construction Projects |
1,613,132.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,153,131.48 |
| R&D expenses |
-- |
| Goodwill |
975,673,564.86 |
| Long-Term Deferred and Prepaid Expenses |
9,046,359.78 |
| Deferred Income Tax Assets |
61,397,841.99 |
| Other Non-Current Assets |
269,637,379.88 |
| Sub-Total of Non-Current Assets |
1,612,064,664.89 |
| Total Assets |
7,512,198,235.27 |
| Short-Term Loans |
887,746,024.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,841,562,445.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,588,280.72 |
| Taxes Payable |
226,908,991.04 |
| Interest Payable |
-- |
| Dividend Payable |
295,218.30 |
| Other payables |
48,080,878.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,024,921.71 |
| Other Current Liabilities |
14,981,966.99 |
| Sub-Total of Current Liabilities |
3,309,363,837.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
725,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,322,354.34 |
| Total Liabilities |
3,341,686,191.50 |
| Paid-In Capital(Or Share Stock) |
1,322,425,609.00 |
| Capital Surplus |
3,299,941,362.68 |
| Surplus Reserve |
149,593,002.95 |
| LESS:Treasury Stock |
11,719,984.77 |
| Undistributed Profits |
-675,560,214.10 |
| Minority Stockholder's Interest |
95,252,268.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,075,259,775.76 |
| Owner's Equity（Stockholder's Equity） |
4,170,512,043.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,512,198,235.27 |
